CABG still standard for 3V CAD

In this large multicenter randomized trial of almost 2000 patients with 3 vessel or left main CAD, patients were randomized to CABG or PCI. PCI was found to have higher rates of adverse cardiac and cerebrovascular events (18% vs 12%) at 12 months (primarily driven by repeat revascularization). Death and MI rates were similar, although CABG patients had a higher risk of stroke (2.2% vs 0.6%). For now, CABG should remain the standard for revascularization of patients with 3 vessel or Left main CAD (abstract)

Danielle Scheurer

Dr. Scheurer is a clinical hospitalist and the Medical Director of Quality and Safety at the Medical University of South Carolina in Charleston, South Carolina, and is Assistant Professor of Medicine. She is a graduate of the University of Tennessee College of Medicine, completed her residency at Duke University, and completed her Masters in Clinical Research at the Medical University of South Carolina. She also serves as the Web Editor and Physician Advisor for the Society of Hospital Medicine.

Leave a Comment